Adicet Bio Inc ACET:NASDAQ

Last Price$12.99NASDAQ Closing Price as of 4:00PM ET 1/24/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change+1.06(8.89%)
Bid (Size)$12.00 (2)
Ask (Size)$13.00 (3)
Day Low / High$11.13 - 13.07
Volume404.3 K
 

Read more news Recent News

Insider Buy: Adicet Bio
6:54AM ET 12/13/2021 MT Newswires

Andrew Sinclair, Director, on December 08, 2021, executed a purchase for 500,000 shares in Adicet Bio (ACET) for $7,000,000. Following the Form 4 filing...

Adicet Bio Closes $100.6 Million Common Stock Offering
4:10PM ET 12/10/2021 MT Newswires

Adicet Bio (ACET) said late Friday it closed its public offering of about 7.19 million common shares at $14 each, raising $100.6 million in gross proceeds....

Adicet Bio Prices Common Stock Offering at $14 Per Share
3:18AM ET 12/08/2021 MT Newswires

Adicet Bio (ACET) on Wednesday priced a public offering of about 6.3 million common shares at $14 per share for expected gross proceeds of $87.5 million....

Adicet Bio Commences Common Stock Offering
4:30PM ET 12/07/2021 MT Newswires

Adicet Bio (ACET) said late Tuesday it has launched a public offering of an undisclosed amount its common shares. The biotechnology company plans to grant...

View all Commentary and Analysis

Adicet Bio (ACET) Investor Presentation - Slideshow
10:23AM ET 8/13/2021 Seeking Alpha

Week 17 MDA Breakout Stocks - April 2021: Short-Term Picks To Give You An Edge
7:08AM ET 4/25/2021 Seeking Alpha

LAVA Therapeutics Seeks $101 Million U.S. IPO
1:30PM ET 3/22/2021 Seeking Alpha

Adicet Bio (ACET) Investor Presentation - Slideshow
4:27AM ET 2/28/2021 Seeking Alpha

Company Profile

Business DescriptionAdicet Bio, Inc. is a biotechnology company, which engages in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA. View company web site for more details
Address500 Boylston Street
Boston, Massachusetts 02116
Phone+1.857.315.5528
Number of EmployeesN/A
Recent SEC Filing01/11/20224
President, CEO, Secretary & DirectorChen Schor
Chief Financial OfficerBrian Nicholas Harvey
Chief Medical Officer & Senior Vice PresidentFrancesco Galimi
Chief Technology OfficerDonald Healey

Company Highlights

Price Open$11.87
Previous Close$11.93
52 Week Range$6.25 - 18.49
Market Capitalization$415.1 M
Shares Outstanding32.0 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement03/10/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$2.05
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit Margin-570.14%
Return on Equity-27.86%

Analyst Ratings as of 05/17/2021

Buy
7
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset